Improvements to existing anti-infective agents and repurposing drugs
Session 3: Improvements to existing anti-infective agents and repurposing drugs
Monday 3 April
The arms race between the development of new anti-infective agents and rise of resistance has been a stalemate for the past 60 years largely due to the development of new generations of existing antibiotics. This session will examine what further improvements are in the pipeline, and the complementary approach of repurposing medications approved for one indication to target a different pathogen.